USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
BIORASIS, INC.
Address:
23 Fellen Road
Storrs, CT 06269-0158
Phone:
N/A
URL:
N/A
EIN:
126015117
DUNS:
807026484
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,051,387.00 2
SBIR Phase II $486,406.00 1

Award List:

Needle-Implantable, Wireless Multi-Sensor for Continuous Glucose Monitoring

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$901,387.00
Agency:
HHS
Principal Investigator:
Ioannis Tomazos
Abstract:
DESCRIPTION (provided by applicant): Background: Over the past five years, the University of Connecticut together with its start-up spin-off corporation (Biorasis Inc.) has been developing a totally implantable biosensor platform (0.5 mm x 0.5 mm x 5 mm) c apable of continuously monitoring glucose.… More

SBIR Phase I: Self Calibrating, Wireless, Needle Implantable Sensor for Continuous Glucose Monitoring

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$150,000.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project aims to develop a wireless, needle implantable miniaturized (0.5 x 0.5 x 5 mm) sensor for continuous glucose monitoring, with provisions for internal self-calibration without the need for frequent, external fingerpricking. The proposed… More

SBIR Phase II: Self Calibrating, Wireless, Needle Implantable Sensor for Continuous Glucose Monitoring

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$486,406.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase II project aims to develop a wireless, needle implantable miniaturized (0.5 x 0.5 x 5 mm) sensor for continuous glucose monitoring, with provisions for internal self-calibration that ultimately eliminates the need for frequent, external… More